Korro Bio, Inc. Gain (Loss) on Extinguishment of Debt
Korro Bio, Inc. (KRRO) reported Gain (Loss) on Extinguishment of Debt of -$269.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2020-03-26
- Korro Bio, Inc. gain (loss) on extinguishment of debt for fiscal 2018 was -$269.00K.
- Korro Bio, Inc. gain (loss) on extinguishment of debt for fiscal 2017 was -$3.75M.
| Period end | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|
| 2018-12-31 | -$269.00K 10-K · filed 2020-03-26 |
| 2017-12-31 | -$3.75M 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |